A Spanish SME specialised in bioinformatics and computational biology looks for a gene-editing European company wishing to join a research consortium who will apply for the MSCA-ITN-ETN-2018 with a project aimed at studying mobile genetic elements (Life Sciences, LIF panel). They are looking for a company to participate as a beneficiary, and thus to recruit and host an Early-Stage Researcher who will develop a PhD thesis.
The research project will investigate mobile elements under the assumption that transposons, viruses and repeats are all (in one way or another) mobile elements or at least dynamic nucleotide elements, either DNA (DeoxyriboNucleicAcid) or RNA (RiboNucleicAcid). Mobile elements question the genome sequence stability and provide the basis for species adaptation and evolution. They are also of great importance in genetic engineering, since they are powerful tools for genome editing, gene regulation and horizontal gene transfer. They are for instance essential for some popular and well-timed topics such as antibiotic resistance, genetic mutations causing cancer and other diseases, therefore anticipating a potential treatment for these prevalent diseases. Despite their roles, the understanding of mobile elements is still in a very early stage, probably in its infancy.
The research consortium is already composed of a multidisciplinary group of academic and non-academic institutions (9 for the moment) specialised in the research topics of interest, with one of the academic partners studying casposons with the CRISPR genome editing technology angle, which can be programmed to specifically target particular stretches of genetic code and to edit DNA at precise locations, thus allowing researchers to permanently modify genes in living cells and organisms (e.g. to treat genetic diseases).
The Spanish company seeks for a European (EU member state or associated country) company specialised in gene editing, wishing to develop a sub-project within the framework of a European Training Network investigating mobile elements. The gene-editing company will host and supervise an Early-Stage Researcher who will develop a PhD thesis, and will therefore receive funding from the EC and claim for costs (researcher and institutional costs).
Deadline for EoIs: 24th September 2017
- Specific area of activity of the partner: Type of partner sought. European (EU member state or associated country) R&D company specialised in gene-editing.
Role of partner sought. Beneficiary in a H2020-MSCA-ITN, so to develop a research sub-project in the context of the main project by hosting and supervising an Early Stage Researcher who will develop a PhD at his premises.
Proposal under development
Acronym: MObile Genetic Elements as BIOengineering Tools and OMIC ArchitectS for the Evolution of Complex Life (MOBIOMICS)
Website: Not open already. Expected to be open on October 2017 (Scoping Paper for Horizon 2020 work programme 2018-2020 Marie Sklodowska-Curie Actions). Link to the latest call: https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topic
Duration: 192 week(s)
Coordinator required: No
01/05/2018 - Selling Online Internationally - Shetland
02/05/2018 - Selling Online Internationally - Orkney